Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuropsychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/npp.2017.194PMID 28849779PMCID PMC5729569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study

  2018cited by this paper
• Ketamine Treatment and Global Brain Connectivity in Major Depression

  2017cited by this paper
• Psychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth

  2017cited by this paper
• Ketamine as a Treatment for Adolescent Depression: A Case Report.

  2017cited by this paper
• Ketamine Mechanism of Action: Separating the Wheat from the Chaff

  2017cited by this paper
• Prophylactic Ketamine Attenuates Learned Fear

  2017cited by this paper
• GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

  2017cited by this paper
• Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

  2017cited by this paper
• Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders

  2017cited by this paper
• Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function

  2016cited by this paper
• Activation of a ventral hippocampus–medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine

  2016cited by this paper
• Effect of as‐needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder

  2016cited by this paper
• Ketamine for Depression: An Update.

  2016cited by this paper
• Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

  2016cited by this paper
• Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.

  2015cited by this paper
• Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial.

  2015cited by this paper
• Trajectories of change in youth anxiety during cognitive-behavior therapy.

  2015cited by this paper
• A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder

  2015cited by this paper
• Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

  2014cited by this paper
• Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

  2014cited by this paper
• Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

  2014cited by this paper
• Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.

  2014cited by this paper
• Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

  2013cited by this paper
• Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

  2013cited by this paper
• Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

  2013cited by this paper
• Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

  2013cited by this paper
• Severity classification on the Hamilton Depression Rating Scale.

  2013cited by this paper
• Effects of ketamine in treatment-refractory obsessive-compulsive disorder.

  2012cited by this paper
• State-Trait Anxiety Inventory for Adults

  2012cited by this paper
• Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

  2012cited by this paper
• The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

  2011cited by this paper
• Psychometric evaluation of a visual analog scale for the assessment of anxiety

  2010cited by this paper
• Neuroimaging in social anxiety disorder: a systematic review of the literature.

  2010cited by this paper
• Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.

  2010cited by this paper
• Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

  2009cited by this paper
• High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.

  2008cited by this paper
• The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

  2007cited by this paper
• A one-item question with a Likert or Visual Analog Scale adequately measured current anxiety.

  2007cited by this paper
• The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans

  2007cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla

  2005cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

  2005cited by this paper
• Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

  2003cited by this paper
• The impairments caused by social phobia in the general population: implications for intervention

  2003cited by this paper
• Reliability Generalization of Scores on the Spielberger State-Trait Anxiety Inventory

  2002cited by this paper
• The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction.

  2002cited by this paper
• Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale.

  2002cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Social Phobia

  2000cited by this paper
• Psychometric properties of the Liebowitz Social Anxiety Scale

  1999cited by this paper
• Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS)

  1998cited by this paper
• Social phobia.

  1987cited by this paper
• Reliability and Concurrent Validity of Three Visual-Analogue Mood Scales

  1986cited by this paper
• Manual for the State-Trait Anxiety Inventory (STAI) (Form Y

  1983cited by this paper
• Measurement of feelings using visual analogue scales.

  1969cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Ketamine in clinical practice: transitioning from anesthetic agent to psychiatric therapeutic

  2025cites this paper
• Antidepressant Efficacy of Ketamine Plus Naltrexone for Major Depression Comorbid with Alcohol Use Disorder: A Randomized Controlled Trial.

  2025cites this paper
• Pharmacological strategies for treating social anxiety disorder in adults: a systematic review of studies published since 2015

  2025cites this paper
• Effects of ketamine and esketamine on death, suicidal behaviour, and suicidal ideation in psychiatric disorders: A systematic review and meta-analysis

  2025cites this paper
• Ketamine Reverses Chronic Stress‐Induced Behavioral Changes via the Expression of Ca2+‐Permeable AMPA Receptors in Mice

  2025cites this paper
• Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder.

  2025cites this paper
• Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review.

  2025cites this paper
• Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study

  2025cites this paper
• Momentary Brain Imaging Assessment of Neuroplasticity in Psychiatric Illness: Protocol for Systematic Review

  2025cites this paper
• PROPHYLACTIC KETAMINE: CURRENT KNOWLEDGE AND FUTURE DIRECTIONS.

  2025cites this paper
• Neuropharmacology and the Applications of Herbal Extracts Found within Sri Lankan Traditional Anxiety Remedies

  2025cites this paper
• Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice

  2025cites this paper
• Prefrontal ErbB4-positive interneurons for avoidance.

  2025cites this paper
• Challenges and hopes for treatment of anxiety disorder in the autistic population.

  2025cites this paper
• New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

  2025influential citation
• Interleaved Propofol‐Ketamine Maintains DBS Physiology and Hemodynamic Stability: A Double‐Blind Randomized Controlled Trial

  2024cites this paper
• Improvement of Mental Health Symptoms in Response to Ketamine Therapy in Medicaid-Eligible Patients

  2024cites this paper
• Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices

  2024influential citation
• General anesthesia activates a central anxiolytic center in the BNST

  2024cites this paper
• Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis

  2024cites this paper
• Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish.

  2024cites this paper
• Cannabis Use and Its Interaction with Anxiety Disorders

  2024cites this paper
• Ketamine's Altered States Meta-Analysis

  2024cites this paper
• Entactogen Effects of Ketamine: A Reverse-Translational Study.

  2024cites this paper
• Ketamine’s Amelioration of Fear Extinction in Adolescent Male Mice Is Associated with the Activation of the Hippocampal Akt-mTOR-GluA1 Pathway

  2024cites this paper
• Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical Outcomes

  2024cites this paper
• A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy

  2023cites this paper
• KETAMINE IN PERIOPERATIVE DEPRESSIVE SYMPTOMS (PDS) IMPROVEMENT - REVIEW

  2023cites this paper
• General Anesthesia Activates a Central Anxiolytic Center in the BNST

  2023cites this paper
• Efficacy and Safety of Psychedelics in Treating Anxiety Disorders

  2023cites this paper
• Oral ketamine may offer a solution to the ketamine conundrum

  2023cites this paper
• A systematic review of the incidence of medical serious adverse events in sub-anesthetic ketamine treatment of psychiatric disorders.

  2023cites this paper
• A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial

  2023cites this paper
• Deep brain stimulation surgery under ketamine induced conscious sedation: a double blind randomized controlled trial

  2023cites this paper
• Ketamine in neuropsychiatric disorders: an update

  2023influential citation
• A Comparison of the Anti-Anxiety Effects of Oral Ketamine and Fluvoxamine in Children with Separation Anxiety Disorder Manifesting as School Refusal

  2023influential citation
• Novel Ketamine and Zinc Treatment for Anorexia Nervosa and the Potential Beneficial Interactions With the Gut Microbiome.

  2023cites this paper
• Increased Demand for Ketamine Infusions and Associated Complexities

  2023cites this paper
• The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: A systematic review and meta-analysis

  2022influential citation
• Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection

  2022cites this paper
• Clinical Uses of Ketamine in Children: A Narrative Review

  2022cites this paper
• Clinical use of ketamine in psychiatric disorders

  2022cites this paper
• PROTOCOL: Effects of virtual reality exposure therapy versus in vivo exposure in treating social anxiety disorder in adults: A systematic review and meta‐analysis

  2022cites this paper
• Larval Zebrafish as a Model for Mechanistic Discovery in Mental Health

  2022cites this paper
• The Effect of the Low Glutamate Diet on the Reduction of Psychiatric Symptoms in Veterans With Gulf War Illness: A Pilot Randomized-Controlled Trial

  2022cites this paper
• Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment.

  2022cites this paper
• Asleep DBS under ketamine sedation: Proof of concept.

  2022cites this paper
• Ketamine treatment for depression: a review

  2022cites this paper
• Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction

  2022cites this paper
• A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

  2022cites this paper
• New frontiers in the pharmacological treatment of social anxiety disorder in adults: an up-to-date comprehensive overview

  2022cites this paper
• Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.

  2022cites this paper
• Oral ketamine reduces the experience of stress in people with chronic suicidality.

  2022cites this paper
• A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects

  2022influential citation
• Point-of-care electrochemical sensor for selective determination of date rape drug "ketamine" based on core-shell molecularly imprinted polymer.

  2022cites this paper
• Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

  2021cites this paper
• Depression and Anxiety Disorders

  2021cites this paper
• Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity

  2021cites this paper
• Ketamine for PTSD: Well, Isn't That Special.

  2021cites this paper
• Panic Disorder: A Review of Treatment Options

  2021cites this paper
• Anxiety disorders.

  2021cites this paper
• Fluoxetine and Ketamine Reverse the Depressive but Not Anxiety Behavior Induced by Lesion of Cholinergic Neurons in the Horizontal Limb of the Diagonal Band of Broca in Male Rat

  2021cites this paper
• Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls

  2021cites this paper
• Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric Disorders

  2021cites this paper
• Ketamine For Post-Traumatic Stress Disorders And It's Possible Therapeutic Mechanism.

  2021cites this paper
• The effects of psychosocial stress on item, cued‐pair and emotional memory

  2021cites this paper
• Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice.

  2021cites this paper
• Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.

  2021cites this paper
• The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala–Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders

  2021cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2021cites this paper
• Ketamine in Psychiatric Disorders

  2021cites this paper
• Do baseline anxiety symptoms impact response to IV ketamine in treatment resistant depression?

  2021cites this paper
• Ketamine treatment for refractory anxiety: A systematic review

  2021influential citation
• Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

  2021cites this paper
• Predicting Multiple Relationships of Attention, Post-Event Processing and Interpretation (Self Related) with Social Anxiety of Isfahan Students

  2021cites this paper
• Sleep and anxiety: From mechanisms to interventions.

  2021cites this paper
• Ketamine Sedation Facilitates Asleep DBS: a multicenter retrospective study

  2021cites this paper
• Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

  2021cites this paper
• Mapping gene expression in social anxiety reveals the main brain structures involved in this disorder.

  2020cites this paper
• Antidepressiva

  2020cites this paper
• Evaluation of depressive symptoms in a sample with social anxiety disorder

  2020cites this paper
• The role of dissociation in ketamine’s antidepressant effects

  2020cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2020influential citation
• Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology

  2020cites this paper
• The Effects of Social Stress on Memory: If, How and When

  2020cites this paper
• Treatment Response Biomarkers in Anxiety Disorders: From Neuroimaging to Neuronally-Derived Extracellular Vesicles and Beyond.

  2020cites this paper
• Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale

  2020cites this paper
• Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.

  2020cites this paper
• Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice

  2020cites this paper
• Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression

  2020cites this paper
• Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression?

  2020cites this paper
• Registered clinical trials investigating ketamine for psychiatric disorders.

  2020cites this paper
• Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents.

  2020cites this paper
• Ketamine blocks the correlation between morphine-induced conditioned place preference and anxiety-like behaviors in mice

  2020cites this paper
• Translational Studies in the Complex Role of Neurotransmitter Systems in Anxiety and Anxiety Disorders.

  2020cites this paper
• Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.

  2020cites this paper
• Repurposing Potential of Ketamine: Opportunities and Challenges

  2020cites this paper
• Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study

  2020influential citation
• Ketamine Administration During Hospitalization Is Not Associated With Posttraumatic Stress Disorder Outcomes in Military Combat Casualties: A Matched Cohort Study

  2020cites this paper
• Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus.

  2019cites this paper